Kodiak Sciences shares soar after eye drug succeeds in late-stage study

In the trial, 62.5% of patients who received Zenkuda achieved at least a two-step improvement on a standard retinopathy severity scale at 48 weeks.

Kodiak Sciences shares soar after eye drug succeeds in late-stage study
In the trial, 62.5% of patients who received Zenkuda achieved at least a two-step improvement on a standard retinopathy severity scale at 48 weeks.